AQST - Aquestive Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$9.75
DETAILS
HIGH:
$12.00
LOW:
$6.00
MEDIAN:
$10.00
CONSENSUS:
$9.75
UPSIDE:
94.22%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: AQST has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.